Novel drug candidate for the treatment of several soft-tissue sarcoma histologic subtypes: A computational method using survival-associated gene signatures for drug repurposing

Systemic treatment options for soft tissue sarcomas (STSs) have remained unchanged despite the need for novel drug candidates to improve STS outcomes. Drug repurposing involves the application of clinical drugs to different diseases, reducing development time, and cost. It has also become a fast and...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xia, Huang, Wen-Ting, Wu, Hua-Yu, He, Rong-Quan, Ma, Jie, Liu, An-Gui, Chen, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412453/
https://www.ncbi.nlm.nih.gov/pubmed/30816547
http://dx.doi.org/10.3892/or.2019.7033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412453/
https://www.ncbi.nlm.nih.gov/pubmed/30816547
http://dx.doi.org/10.3892/or.2019.7033

Ejemplares similares